Literature DB >> 16211361

Progestogen only contraception and endometrial break through bleeding.

Oliver P Milling Smith1, Hilary O D Critchley.   

Abstract

Progestogen only contraceptives (POC) provide a safe and effective method of fertility regulation. Unfortunately, they are commonly associated with the problem of endometrial break through bleeding (BTB), often leading to discontinuation of use. An increase in endometrial vascular fragility has been demonstrated as an important mechanism that contributes to BTB but our understanding of the interaction between exogenous steroid use and endometrial vasculature remains incomplete. This review sets out to describe a number of commonly used POC, their effects on endometrial morphology and possible molecular and cellular mechanisms that may lead to unscheduled bleeding.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16211361     DOI: 10.1007/s10456-005-9003-z

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  7 in total

1.  Uterine microRNA signature and consequence of their dysregulation in uterine disorders.

Authors:  Nasser Chegini
Journal:  Anim Reprod       Date:  2010-07       Impact factor: 1.807

Review 2.  MicroRNA signature and regulatory functions in the endometrium during normal and disease states.

Authors:  Qun Pan; Nasser Chegini
Journal:  Semin Reprod Med       Date:  2008-10-24       Impact factor: 1.303

Review 3.  Iatrogenic unscheduled (breakthrough) endometrial bleeding.

Authors:  M Hickey; I S Fraser
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

4.  High dose of green tea infusion normalized spiral artery density in rats treated with the depot-medroxyprogesterone acetate.

Authors:  A S Emilda; Nora Veri; Alchalidi Alchalidi
Journal:  J Intercult Ethnopharmacol       Date:  2016-10-04

5.  Bleeding profile of women using a drospirenone-only pill 4 mg over nine cycles in comparison with desogestrel 0.075 mg.

Authors:  S Palacios; E Colli; P A Regidor
Journal:  PLoS One       Date:  2020-06-29       Impact factor: 3.240

6.  A multicenter, double-blind, randomized trial on the bleeding profile of a drospirenone-only pill 4 mg over nine cycles in comparison with desogestrel 0.075 mg.

Authors:  Santiago Palacios; Enrico Colli; Pedro-Antonio Regidor
Journal:  Arch Gynecol Obstet       Date:  2019-11-14       Impact factor: 2.344

7.  Progestins Related to Progesterone and Testosterone Elicit Divergent Human Endometrial Transcriptomes and Biofunctions.

Authors:  Sahar Houshdaran; Joseph C Chen; Júlia Vallvé-Juanico; Shayna Balayan; Kim Chi Vo; Karen Smith-McCune; Ruth M Greenblatt; Juan C Irwin; Linda C Giudice
Journal:  Int J Mol Sci       Date:  2020-04-09       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.